Home / Products / Cancer (Tumor) Cell Lines / TF-1
TF-1
Datasheet Protocol

TF-1

Cat. No. ARC0950
Product Type:

Cancer (Tumor) Cell Lines

Species:

Homo sapiens (Human)

Tissue Source:

Bone (bone marrow)

Growth Properties:

Adherent and suspension

In stock
$1,500.00 / Vial
Ask a Question

Short Description 🔒

TF-1 is a cancer cell line of bone (bone marrow) acute erythroid leukemia, isolated from in situ; bone marrow.

Recommended Products

BCORL1 Knockout Hela Polyclonal Cells BCORL1 Knockout Hela Polyclonal Cells Cat. No. ARG21490 HECTD3 Knockout Raji Polyclonal Cells HECTD3 Knockout Raji Polyclonal Cells Cat. No. ARG23680 HSD17B12 Knockout MES-OV Polyclonal Cells HSD17B12 Knockout MES-OV Polyclonal Cells Cat. No. ARG24578 GUF1 Knockout Hela Polyclonal Cells GUF1 Knockout Hela Polyclonal Cells Cat. No. ARG25512 CAPN2 Knockout HT29 Polyclonal Cells CAPN2 Knockout HT29 Polyclonal Cells Cat. No. ARG42195 CTSC Knockout MES-OV Polyclonal Cells CTSC Knockout MES-OV Polyclonal Cells Cat. No. ARG6591
Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Product Type:
Cancer (Tumor) Cell Lines
Species:
Homo sapiens (Human)
Tissue Source:
Bone (bone marrow)
Disease:
Acute erythroid leukemia
Growth Mode:
Adherent and suspension
Age:
35 years
Sex of Donor:
Male
Derived From Site:
In situ; Bone marrow
Size/Quantity:
1 million
Shipping info:
Cryopreserved in vials and shipped on dry ice

Cell Engineering Information

No cell engineering information available.

Immortalization Information

No immortalization information available.

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Mycoplasma testing:
Negative for mycoplasma through PCR analysis
Sterility testing:
Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.
Pathogens:
Cells tested negative for HIV-1, HBV, and HCV.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description 🔒

Complete description is available upon request.

Related Products You May Also Like

HARBI1 Knockout HAP1 Polyclonal Cells

HARBI1 Knockout HAP1 Polyclonal Cells

Cat. No. ARG22453
 GPHN Knockout Raji Polyclonal Cells

GPHN Knockout Raji Polyclonal Cells

Cat. No. ARG23613
 INF2 Knockout jurkat Polyclonal Cells

INF2 Knockout jurkat Polyclonal Cells

Cat. No. ARG34336
 AGO2 Knockout HEK293T Polyclonal Cells

AGO2 Knockout HEK293T Polyclonal Cells

Cat. No. ARG38110
 DCAF5 Knockout KYSE30 Polyclonal Cells

DCAF5 Knockout KYSE30 Polyclonal Cells

Cat. No. ARG9703
 PARP16 Knockout HCT116 Polyclonal Cells

PARP16 Knockout HCT116 Polyclonal Cells

Cat. No. ARG7100